Indeed, it was shown that there is a “cadherin modulation” in advanced BlCa, where the epithelial marker E-cadherin is expressed at lower levels, simultaneously with high levels of mesenchymal-associated P-cadherin and/or R-cadherin (Martins-Lima et al., 2022). This evidence concerns the gene CDH1 and bladder transitional cell carcinoma.